What if the FDA no longer exists, and any treatment for anything not explicitly forbidden is allowed?

July 2024: Donanemab Approved for Treatment of Early Alzheimer's Disease

Would early detection and treatment suffice, if it does not necessarily work after onset of substantial symptoms? Specifically, if a reliable early detection methodology arises, would you consider early-detected cases to be part of your total set from which you measure 75%?

New drug was just approved. https://www.nature.com/articles/d41586-023-00030-3

What if the cure isn't a drug?

@IsaacKing Any treatment counts.

Updated description

Does this have to be for all forms of Alzheimer's, regardless of cause? Broad efficacy in 80% of cases? What is the bar?

@EdwardKmett Edited the question. For all forms. At least 75% of cases